What is Michelle Corey?
Michelle Corey is dedicated to helping individuals heal from autoimmune diseases through a personalized, root-cause approach. The company offers a suite of services, including one-on-one consulting, video lab reviews, and self-paced learning modules, all designed to address the underlying causes of conditions such as Hashimoto's, lupus, and rheumatoid arthritis. By focusing on holistic support and empowering clients, Michelle Corey aims to guide individuals toward reclaiming their health and vitality, emphasizing the body's innate capacity for healing when optimal conditions are met.
How much funding has Michelle Corey raised?
Michelle Corey has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Michelle Corey
PPP
Public-Private Partnership
What's next for Michelle Corey?
With the recent substantial expansion capital, Michelle Corey is poised for significant growth. The company is expected to leverage this investment to scale its operations, potentially enhancing its program offerings and expanding its reach to a broader audience seeking effective solutions for autoimmune conditions. This strategic financing at a Series B/C stage suggests a focus on market penetration and further development of its unique healing methodologies, solidifying its position in the functional health sector.
See full Michelle Corey company page
